Jefferies Financial Group
ACHV icon

Jefferies Financial Group’s Achieve Life Sciences ACHV Stock Holding History

Jefferies Financial Group’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,572
Closed -$37K – 1628
2026
Q1 		$37K Sell
12,572
-4,241
-25% -$18.8K ﹤0.01% 1657
2025
Q4 		$83.6K Buy
+16,813
New +$73.3K ﹤0.01% 1723
2024
Q2 		– Sell
-11,500
Closed -$52.3K – 1374
2024
Q1 		$52.3K Buy
+11,500
New +$51K ﹤0.01% 1489

Other funds holding ACHV

Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TPG GP A
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Logos Global Management
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Jefferies Financial Group's ACHV Position: Q2 2026 in Review

Jefferies Financial Group sold out of Achieve Life Sciences (ACHV) in Q2 2026, closing a stake of 12,572 shares — an estimated $37K sold.

Jefferies Financial Group first reported a position in ACHV in Q1 2024 and held it in 3 quarters. The position peaked at $83.6K in Q4 2025. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Jefferies Financial Group reported no remaining Achieve Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 12,572 Achieve Life Sciences shares in Q2 2026, an estimated $37K.
  • Jefferies Financial Group first reported a position in Achieve Life Sciences in Q1 2024 and held it in 3 quarters.
  • Jefferies Financial Group's Achieve Life Sciences position peaked at $83.6K in Q4 2025.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.